サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1493309

バイオマテリアルの市場規模、シェア、動向分析レポート：製品別、用途別、地域別、セグメント予測、2024年～2030年

Biomaterials Market Size, Share & Trends Analysis Report By Product (Natural, Metallic, Polymer), By Application (Cardiovascular, Orthopedics, Plastic Surgery), By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 170 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
バイオマテリアルの市場規模、シェア、動向分析レポート：製品別、用途別、地域別、セグメント予測、2024年～2030年
出版日: 2024年05月23日
発行: Grand View Research
ページ情報: 英文 170 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオマテリアル市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のバイオマテリアル市場規模は2030年までに4,887億米ドルに達し、予測期間中のCAGRは15.6％を記録すると予測されています。

生体材料の応用は、生物医学研究において急成長している分野です。生体材料の生物活性、適合性、機械的特性の改善における最近の進歩は、組織工学、免疫工学、ドラッグデリバリーシステムへの応用に新たな機会をもたらしています。

高分子バイオマテリアルの生体適合性、低毒性、再生可能な性質は、制御された標的ドラッグデリバリーにおいて強力なドラッグデリバリー剤となり、市場成長に有利な機会をもたらしています。PEGコーティングリポソーム、バイオポリマーコーティングリポソーム、ナノマテリアルドラッグデリバリーなどの改良型ドラッグデリバリーアプローチの登場は、製薬・医療産業におけるバイオポリマーの展望をさらに広げています。

生体材料の使用は、心肺系の再生に大いに役立っています。これらの材料は、播種された細胞に物理的な支持と生理的・化学的な手がかりを与え、組織再生プロセスを支援します。バイオマテリアルとナノテクノロジー技術の統合は、損傷した心筋細胞の細胞外マトリックスの再生も刺激するため、従来の臓器移植に取って代わる。

バイオマテリアル市場レポートハイライト

  • 天然および合成の分解性ポリマーの入手性が高く、外科用縫合糸やインプラントとして幅広く使用されていることから、ポリマー製品セグメントの売上高シェアが最大となった。
  • 天然物は、新薬開発のための新規生理活性物質の供給源として絶大な人気を得ており、この分野の急成長につながった。
  • 慢性的な骨格や筋骨格系の疾患の発生率の増加は、整形外科用途のバイオマテリアルの需要を大規模に引き上げると予想されています。
  • コロナウイルス、すなわちSARS-COV-2による感染は、ポリメラーゼ連鎖反応（PCR）または非PCR法に基づく既存の生物医学的装置を使用して検出することができます。
  • 被膜拘縮を防ぐためのシリコン乳房インプラントの表面改質の改善は、形成外科セグメントにおけるバイオマテリアルの使用を最も速い速度で促進する要因の一つです。
  • バイオセンサーは、組織、酵素、オルガネラなど、微生物が産生する生体分子や生物学的要素のような分析物を検出するために使用される分析装置です。
  • 北米は、イベント開催や資金援助イニシアティブによってバイオマテリアルの利用を促進する官民機関の存在により、収益シェアで市場を独占すると予想されます。
  • アジア太平洋地域は、主に中国で低コストのバイオマテリアル製品を開発する現地メーカーが複数存在するため、急成長が見込まれています。
  • 同市場には、メドトロニック、エボニック、DSM、BASF、バークレー・アドバンスト・バイオマテリアル、コバロン・テクノロジーズ、ジンマー・バイオメット・ホールディングスなどの有力企業が進出しています。
  • 各社は市場での存在感を高めるため、新製品の開発、提携、地域拡大など、いくつかの戦略的成長イニシアチブに取り組んでいます。
  • 例えば、2022年3月、メドトロニックは、Vizientとの協業を発表し、VizientのポートフォリオにTouch Surgery Enterpriseを追加しました。このプラットフォームは、AIを活用したビデオ管理と分析プラットフォームであり、手術チームに手順の記録と洞察への簡単なアクセスを提供します。

目次

第1章 調査手法と範囲

第2章 バイオマテリアル市場：エグゼクティブサマリー

  • 市場スナップショット
  • セグメントスナップショット
  • 競合情勢のスナップショット

第3章 バイオマテリアル市場の変数、動向、範囲

  • 市場セグメンテーションと範囲
  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助市場見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • バイオマテリアル市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTLE分析

第4章 バイオマテリアル市場：製品推定・動向分析

  • セグメントダッシュボード
  • 世界のバイオマテリアル市場製品別展望
  • 2018年から2030年までの市場規模と予測および動向分析
  • 金属
  • 天然
  • セラミック
  • ポリマー

第5章 バイオマテリアル市場：用途推定・動向分析

  • セグメントダッシュボード
  • 世界のバイオマテリアル市場の用途別展望
  • 2018年から2030年までの市場規模と予測および動向分析
  • 心血管
  • 眼科
  • 整形外科
  • 創傷治癒
  • 組織工学
  • 美容整形
  • 神経
  • その他

第6章 バイオマテリアル市場：地域ビジネス分析

  • 地域市場ダッシュボード
  • 世界地域市場スナップショット
  • 市場規模と予測動向分析、2018年から2030年：
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第7章 バイオマテリアル市場：競合情勢

  • 参入企業
  • 戦略マッピング
  • 企業市況分析、2023年
  • 参入企業の概要
  • Medtronic
  • Evonik Industries AG
  • Carpenter Technology Corporation
  • Berkeley Advanced Biomaterials
  • Invibio Ltd
  • Zimmer Biomet Holdings, Inc
  • BASF SE
  • Covalon Technologies Ltd
  • Stryker
  • Johnson & Johnson
  • Dentsply Sirona
  • CoorsTek Inc
  • Corbion
  • Regenity Biosciences
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Biomaterials Market, Region, 2018 - 2030 (USD Million)
  • Table 3 North America Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 North America Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 5 U.S. Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 6 U.S. Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Canada Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 8 Canada Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 9 Europe Biomaterials Market, Region, 2018 - 2030 (USD Million)
  • Table 10 Europe Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 11 Europe Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 12 UK Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 13 UK Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 Germany Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 Germany Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 16 France Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 17 France Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 18 Italy Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 19 Italy Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Spain Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 21 Spain Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 22 Sweden Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Sweden Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Norway Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 25 Norway Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 26 Denmark Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 Denmark Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific Biomaterials Market, Region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 31 Japan Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 Japan Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 China Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 34 China Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 35 India Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 36 India Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 37 Australia Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 38 Australia Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 South Korea Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 40 South Korea Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 41 Thailand Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 42 Thailand Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 43 Latin America Biomaterials Market, Region, 2018 - 2030 (USD Million)
  • Table 44 Latin America Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 45 Latin America Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 46 Brazil Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 47 Brazil Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 48 Mexico Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 49 Mexico Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 50 Argentina Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 51 Argentina Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 MEA Biomaterials Market, Region, 2018 - 2030 (USD Million)
  • Table 53 MEA Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 54 MEA Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 South Africa Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 56 South Africa Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 59 UAE Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 60 UAE Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 61 Kuwait Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait Biomaterials Market, By Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews In North America
  • Fig. 5 Primary Interviews In Europe
  • Fig. 6 Primary Interviews In APAC
  • Fig. 7 Primary Interviews In Latin America
  • Fig. 8 Primary Interviews In MEA
  • Fig. 9 Market Research Approaches
  • Fig. 10 Value-Chain-Based Sizing & Forecasting
  • Fig. 11 QFD Modeling For Market Share Assessment
  • Fig. 12 Market Formulation & Validation
  • Fig. 13 Biomaterials Market: Market Outlook
  • Fig. 14 Biomaterials Competitive Insights
  • Fig. 15 Parent Market Outlook
  • Fig. 16 Related/Ancillary Market Outlook
  • Fig. 17 Penetration And Growth Prospect Mapping
  • Fig. 18 Industry Value Chain Analysis
  • Fig. 19 Biomaterials Market Driver Impact
  • Fig. 20 Biomaterials Market Restraint Impact
  • Fig. 21 Biomaterials Market Strategic Initiatives Analysis
  • Fig. 22 Biomaterials Market: Product Movement Analysis
  • Fig. 23 Biomaterials Market: Product Outlook And Key Takeaways
  • Fig. 24 Logistics & distribution Market Estimates And Forecast, 2018 - 2030
  • Fig. 25 Metallic Market Estimates And Forecast, 2018 - 2030
  • Fig. 26 Natural Market Estimates And Forecast, 2018 - 2030
  • Fig. 27 Ceramics Market Estimates And Forecast, 2018 - 2030
  • Fig. 28 Polymers Market Estimates And Forecast, 2018 - 2030
  • Fig. 29 Biomaterials Market: Application Movement Analysis
  • Fig. 30 Biomaterials Market: Application Outlook And Key Takeaways
  • Fig. 31 Cardiovascular Market Estimates And Forecasts, 2018 - 2030
  • Fig. 32 Ophthalmology Market Estimates And Forecasts, 2018 - 2030
  • Fig. 33 Dental Market Estimates And Forecasts, 2018 - 2030
  • Fig. 34 Orthopedic Market Estimates And Forecasts, 2018 - 2030
  • Fig. 35 Wound Healing Market Estimates And Forecasts, 2018 - 2030
  • Fig. 36 Tissue Engineering Market Estimates And Forecasts, 2018 - 2030
  • Fig. 37 Plastic Surgery Market Estimates And Forecasts, 2018 - 2030
  • Fig. 38 Neurology Market Estimates And Forecasts, 2018 - 2030
  • Fig. 39 Others Market Estimates And Forecasts, 2018 - 2030
  • Fig. 40 Global Biomaterials Market: Regional Movement Analysis
  • Fig. 41 Global Biomaterials Market: Regional Outlook And Key Takeaways
  • Fig. 42 Global Biomaterials Market Share And Leading Players
  • Fig. 43 North America Market Share And Leading Players
  • Fig. 44 Europe Market Share And Leading Players
  • Fig. 45 Asia Pacific Market Share And Leading Players
  • Fig. 46 Latin America Market Share And Leading Players
  • Fig. 47 Middle East & Africa Market Share And Leading Players
  • Fig. 48 North America: SWOT
  • Fig. 49 Europe SWOT
  • Fig. 50 Asia Pacific SWOT
  • Fig. 51 Latin America SWOT
  • Fig. 52 MEA SWOT
  • Fig. 53 North America, By Country
  • Fig. 54 North America
  • Fig. 55 North America Market Estimates And Forecasts, 2018 - 2030
  • Fig. 56 U.S.
  • Fig. 57 U.S. Market Estimates And Forecasts, 2018 - 2030
  • Fig. 58 Canada
  • Fig. 59 Canada Market Estimates And Forecasts, 2018 - 2030
  • Fig. 60 Europe
  • Fig. 61 Europe Market Estimates And Forecasts, 2018 - 2030
  • Fig. 62 UK
  • Fig. 63 UK Market Estimates And Forecasts, 2018 - 2030
  • Fig. 64 Germany
  • Fig. 65 Germany Market Estimates And Forecasts, 2018 - 2030
  • Fig. 66 France
  • Fig. 67 France Market Estimates And Forecasts, 2018 - 2030
  • Fig. 68 Italy
  • Fig. 69 Italy Market Estimates And Forecasts, 2018 - 2030
  • Fig. 70 Spain
  • Fig. 71 Spain Market Estimates And Forecasts, 2018 - 2030
  • Fig. 72 Denmark
  • Fig. 73 Denmark Market Estimates And Forecasts, 2018 - 2030
  • Fig. 74 Sweden
  • Fig. 75 Sweden Market Estimates And Forecasts, 2018 - 2030
  • Fig. 76 Norway
  • Fig. 77 Norway Market Estimates And Forecasts, 2018 - 2030
  • Fig. 78 Asia Pacific
  • Fig. 79 Asia Pacific Market Estimates And Forecasts, 2018 - 2030
  • Fig. 80 China
  • Fig. 81 China Market Estimates And Forecasts, 2018 - 2030
  • Fig. 82 Japan
  • Fig. 83 Japan Market Estimates And Forecasts, 2018 - 2030
  • Fig. 84 India
  • Fig. 85 India Market Estimates And Forecasts, 2018 - 2030
  • Fig. 86 Thailand
  • Fig. 87 Thailand Market Estimates And Forecasts, 2018 - 2030
  • Fig. 88 South Korea
  • Fig. 89 South Korea Market Estimates And Forecasts, 2018 - 2030
  • Fig. 90 Australia
  • Fig. 91 Australia Market Estimates And Forecasts, 2018 - 2030
  • Fig. 92 Latin America
  • Fig. 93 Latin America Market Estimates And Forecasts, 2018 - 2030
  • Fig. 94 Brazil
  • Fig. 95 Brazil Market Estimates And Forecasts, 2018 - 2030
  • Fig. 96 Mexico
  • Fig. 97 Mexico Market Estimates And Forecasts, 2018 - 2030
  • Fig. 98 Argentina
  • Fig. 99 Argentina Market Estimates And Forecasts, 2018 - 2030
  • Fig. 100 Middle East And Africa
  • Fig. 101 Middle East And Africa Market Estimates And Forecasts, 2018 - 2030
  • Fig. 102 South Africa
  • Fig. 103 South Africa Market Estimates And Forecasts, 2018 - 2030
  • Fig. 104 Saudi Arabia
  • Fig. 105 Saudi Arabia Market Estimates And Forecasts, 2018 - 2030
  • Fig. 106 UAE
  • Fig. 107 UAE Market Estimates And Forecasts, 2018 - 2030
  • Fig. 108 Kuwait
  • Fig. 109 Kuwait Market Estimates And Forecasts, 2018 - 2030
  • Fig. 110 Market Share Of Key Market Players- Biomaterials Market
目次
Product Code: GVR-2-68038-637-0

Biomaterials Market Growth & Trends:

The global biomaterials market size is expected to reach USD 488.70 billion by 2030, registering a CAGR of 15.6% over the forecast period, according to a new report by Grand View Research, Inc. The application of biomaterials represents a fast-growing field in biomedical research. Recent advances in the improvement of bioactivity, compatibility, and mechanical properties of biomaterials have introduced new opportunities for their application in tissue engineering, immune engineering, and drug delivery systems.

Biocompatibility, low toxicity, and renewable nature of polymeric biomaterials make them potent drug delivery agents in controlled and targeted drug delivery, thus providing lucrative opportunities for the market growth. The advent of improved drug delivery approaches, such as PEG-coated liposomes, biopolymer-coated liposomes, and nanomaterials drug delivery, further expands the prospects of these biopolymers in the pharmaceutical and medical industries.

Use of biomaterials has greatly benefited the regeneration of the cardiopulmonary system. These materials provide physical support and physiological and chemical cues to seeded cells to assist the tissue regeneration process. Integration of biomaterials with nanotechnology techniques also stimulates the regeneration of damaged cardiomyocytes' extracellular matrix, thus replacing the traditional organ transplantation procedures.

Biomaterials Market Report Highlights:

  • High availability of natural and synthetic degradable polymers and their wide usage as surgical sutures and implants resulted in the largest revenue share of the polymers product segment
  • Natural products have gained immense popularity as a source of novel bioactive substance for the development of novel drugs, leading to fastest growth of this segment
  • Increasing incidence of chronic skeletal and musculoskeletal conditions is expected to raise the demand for biomaterials for orthopedics application at a large scale
  • The infection from coronavirus, that is, SARS-COV-2 can be detected using existing biomedical devices which are based on either Polymerase Chain Reaction (PCR) or Non-PCR methods
  • Improvement in the surface modification of silicone breast implants to prevent capsular contracture is one of the factors driving the biomaterial usage in the plastic surgery segment at the fastest rate
  • Biosensor, is an analytical device that is used to detect analytes such as biomolecules or biological elements of species produced by micro-organisms, that is tissues, enzymes, and organelles
  • North America is expected to dominate the market in terms of revenue share owing to the presence of public and private agencies promoting biomaterial usage by hosting events and funding initiatives
  • Asia Pacific is anticipated to grow at a rapid pace owing to the presence of several local manufacturers developing low-cost biomaterial products, mainly in China
  • Prominent players operating in the market include Medtronic, Evonik, DSM, BASF, Berkeley Advanced Biomaterials, Covalon Technologies, and Zimmer Biomet Holdings
  • Companies are engaged in several strategic growth initiatives, such as novel product developments, partnerships, and regional expansion to reinforce their market presence
  • For instance, in March 2022, Medtronic announced a collaboration with Vizient to add Touch Surgery Enterprise to Vizient's portfolio, which is an AI-powered video management and analytical platform that provides surgical teams with simple access to procedural recordings and insights

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Segment
      • 1.1.1.2. Application Segment
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List Of Primary Sources
  • 1.11. List Of Abbreviations

Chapter 2. Biomaterials Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshots
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Biomaterials Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Rising Demand As A Consequence Of Accidental Injuries & Chronic Conditions
      • 3.3.1.2. Advances In Biomaterials Technologies
      • 3.3.1.3. Expansion In The Usage Scope Of Biomaterials
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. High Expense Associated With The Development Of Biomaterials
      • 3.3.2.2. Problems Related To Biocompatibility Of Biomaterials
  • 3.4. Biomaterials Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
    • 3.4.2. PESTLE Analysis

Chapter 4. Biomaterials Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Biomaterials Market By Product Outlook
  • 4.3. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 4.3.1. Metallic
      • 4.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.3.2. Natural
      • 4.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.3.3. Ceramics
      • 4.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.3.4. Polymers
      • 4.3.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 5. Biomaterials Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Biomaterials Market By Application Outlook
  • 5.3. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 5.3.1. Cardiovascular
      • 5.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.2. Sensors
      • 5.3.1.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.3. Stents
      • 5.3.1.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.4. Guidewires
      • 5.3.1.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.5. Implantable Cardiac Defibrillators
      • 5.3.1.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.6. Pacemakers
      • 5.3.1.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.7. Vascular Grafts
      • 5.3.1.7.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.8. Others
      • 5.3.1.8.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.2. Ophthalmology
      • 5.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.2.2. Synthetic Corneas
      • 5.3.2.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.2.3. Intraocular Lens
      • 5.3.2.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.2.4. Contact Lens
      • 5.3.2.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.2.5. Ocular Tissue Replacement
      • 5.3.2.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.2.6. Others
      • 5.3.2.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.3. Dental
      • 5.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.3.2. Tissue Regeneration Materials
      • 5.3.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.3.3. Dental Implants
      • 5.3.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.3.4. Bone Grafts & Substitutes
      • 5.3.3.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.3.5. Dental Membranes
      • 5.3.3.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.3.6. Others
      • 5.3.3.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.4. Orthopedic
      • 5.3.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.4.2. Joint Replacement biomaterials
      • 5.3.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.4.3. Orthobiologics
      • 5.3.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.4.4. Bioresorbable Tissue Fixation Products
      • 5.3.4.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.4.5. Visco supplementation
      • 5.3.4.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.4.6. Spine Biomaterial
      • 5.3.4.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.4.7. Others
      • 5.3.4.7.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.5. Wound Healing
      • 5.3.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.5.2. Fracture Healing Device
      • 5.3.5.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.5.3. Adhesion Barrier
      • 5.3.5.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.5.4. Skin Substitutes
      • 5.3.5.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.5.5. Internal Tissue Sealant
      • 5.3.5.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.5.6. Surgical Hemostats
      • 5.3.5.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.5.7. Others
      • 5.3.5.7.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.6. Tissue Engineering
      • 5.3.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.7. Plastic Surgery
      • 5.3.7.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.2. Facial Wrinkle Treatment
      • 5.3.7.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.3. Soft Tissue Fillers
      • 5.3.7.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.4. Craniofacial Surgery
      • 5.3.7.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.5. Bioengineered Skins
      • 5.3.7.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.6. Peripheral Nerve Repair
      • 5.3.7.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.7. Acellular Dermal Matrices
      • 5.3.7.7.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.8. Others
      • 5.3.7.8.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.8. Neurology
      • 5.3.8.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.8.2. Neural Stem Cell Encapsulation
      • 5.3.8.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.8.3. Shunting Systems
      • 5.3.8.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.8.4. Hydrogel Scaffold For CNS Repair
      • 5.3.8.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.8.5. Cortical Neural Prosthetics
      • 5.3.8.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.8.6. Others
      • 5.3.8.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.9. Others
      • 5.3.9.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 6. Biomaterials Market: Regional Business Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Global Regional Market Snapshot
  • 6.3. Marker Size, & Forecasts Trend Analysis, 2018 To 2030:
  • 6.4. North America
    • 6.4.1. North America Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. U.S. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Canada Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. UK Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Germany Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.4. Spain
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Spain Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.5. France
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. France Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.6. Italy
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Italy Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Denmark Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Competitive Scenario
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Sweden Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Competitive Scenario
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Norway Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Japan Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. China Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. India Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. South Korea Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Thailand Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.6.7. Australia
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Australia Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Brazil Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.7.3. Mexico
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Mexico Biomaterials Market, 2018 - 2030 (USD Million)
    • 6.7.4. Argentina
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Argentina Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Biomaterials Market, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. South Africa Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Saudi Arabia Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. UAE Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Kuwait Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 7. Biomaterials Market: Competitive Landscape

  • 7.1. Participant Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2023
  • 7.4. Participant's Overview
    • 7.4.1. Medtronic
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Evonik Industries AG
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Carpenter Technology Corporation
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Berkeley Advanced Biomaterials
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Invibio Ltd
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Zimmer Biomet Holdings, Inc
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. BASF SE
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Covalon Technologies Ltd
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Stryker
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Johnson & Johnson
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Dentsply Sirona
      • 7.4.11.1. Overview
      • 7.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives
    • 7.4.12. CoorsTek Inc
      • 7.4.12.1. Overview
      • 7.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Strategic Initiatives
    • 7.4.13. Corbion
      • 7.4.13.1. Overview
      • 7.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Strategic Initiatives
    • 7.4.14. Regenity Biosciences
      • 7.4.14.1. Overview
      • 7.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Strategic Initiatives